Texas Drugmaker Called Out for Quality Issues

Drug Industry Daily
A A
The FDA cited OTC drugmaker Quest Specialty of Brenham, Texas, for lacking written quality procedures during a July 31-August 3 inspection.

To View This Article:

Login

Subscribe To Drug Industry Daily